.Avidity Biosciences satisfied financiers along with phase 1/2 data in Duchenne muscle dystrophy (DM...
.Actinogen Medical's cortisol blocker has overlooked the primary endpoint of a phase 2 research in a...
.Antibody-drug conjugates (ADCs) have actually been at the center of many a billion-dollar biobuck l...
.Asset supervisor TPG, which has supported biotechs like Sionna Therapies and Santa Clam Ana Biograp...
.Merck & Co.'s TIGIT program has actually gone through another setback. Months after shuttering a...
.After a year described by pipe cuts, the shift of its chief executive officer and discharges, Exsci...
.Cullinan Therapy was actually blown away good enough with Harbour BioMed's bispecific immune reacto...
.In this full week's episode of "The Leading Line," we're diving into Intense Biotech's yearly Feroc...
.The confetti is actually still flying from Eli Lilly's gathering commemorating the commendation of ...
.Welcome to recently's Chutes & Ladders, our roundup of considerable management hirings, shooting...